Vascular Biogenics Ltd (VBLT)

[Valueinvestor12]

WC, Here is what I am reading between the line. The delay from VBLT till the end of the year telling me that someone influenced dr Dror to do that.I think a big pharma wants to buy VBLT but waiting for the interim report and if things is positive for vb 111 the buyer wants to do a bigger ovarian trial than vblt was thinking about and did not want an SPA demands. Also, the buyer maybe wants vb 111 to be manufacture in the USA where they have a bigger facilties than vblt facility in Modin Israel.remember vblt said before that they will partner with someone else to do thyroid phs3 and someone told them you don't need to partner with another because we want to buy you out. Very interesting I feel great things will be coming out within couple of months. If vblt not confident about vb 111 they will not present at the ASCO this June. GLTA